Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma

Tianlu Chen, Guoxiang Xie, Xiaoying Wang, Jia Fan, Yunping Qiu, Xiaojiao Zheng, Xin Qi, Yu Cao, Mingming Su, Xiaoyan Wang, Lisa X. Xu, Yun Yen, Ping Liu, Wei Jia

Research output: Contribution to journalArticle

178 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) is a common malignancy in the world with high morbidity and mortality rate. Identification of novel biomarkers in HCC remains impeded primarily because of the heterogeneity of the disease in clinical presentations as well as the pathophysiological variations derived from underlying conditions such as cirrhosis and steatohepatitis. The aim of this study is to search for potential metabolite biomarkers of human HCC using serum and urine metabolomics approach. Sera and urine samples were collected from patients with HCC (n = 82), benign liver tumor patients (n = 24), and healthy controls (n = 71). Metabolite profiling was performed by gas chromatography time-of-flight mass spectrometry and ultra performance liquid chromatography-quadrupole time of flight mass spectrometry in conjunction with univariate and multivariate statistical analyses. Forty three serum metabolites and 31 urinary metabolites were identified in HCC patients involving several key metabolic pathways such as bile acids, free fatty acids, glycolysis, urea cycle, and methionine metabolism. Differentially expressed metabolites in HCC subjects, such as bile acids, histidine, and inosine are of great statistical significance and high fold changes, which warrant further validation as potential biomarkers for HCC. However, alterations of several bile acids seem to be affected by the condition of liver cirrhosis and hepatitis. Quantitative measurement and comparison of seven bile acids among benign liver tumor patients with liver cirrhosis and hepatitis, HCC patients with liver cirrhosis and hepatitis, HCC patients without liver cirrhosis and hepatitis, and healthy controls revealed that the abnormal levels of glycochenodeoxycholic acid, glycocholic acid, taurocholic acid, and chenodeoxycholic acid are associated with liver cirrhosis and hepatitis. HCC patients with alpha fetoprotein values lower than 20 ng/ml was successfully differentiated from healthy controls with an accuracy of 100% using a panel of metabolite markers. Our work shows that metabolomic profiling approach is a promising screening tool for the diagnosis and stratification of HCC patients.

Original languageEnglish
JournalMolecular and Cellular Proteomics
Volume10
Issue number7
DOIs
Publication statusPublished - Jul 1 2011
Externally publishedYes

Fingerprint

Biomarkers
Metabolites
Liver
Hepatocellular Carcinoma
Urine
Bile Acids and Salts
Serum
Liver Cirrhosis
Hepatitis
Mass spectrometry
Tumors
Glycochenodeoxycholic Acid
Metabolomics
Glycocholic Acid
Chenodeoxycholic Acid
Inosine
Taurocholic Acid
Liquid chromatography
alpha-Fetoproteins
Mass Spectrometry

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Molecular Biology

Cite this

Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. / Chen, Tianlu; Xie, Guoxiang; Wang, Xiaoying; Fan, Jia; Qiu, Yunping; Zheng, Xiaojiao; Qi, Xin; Cao, Yu; Su, Mingming; Wang, Xiaoyan; Xu, Lisa X.; Yen, Yun; Liu, Ping; Jia, Wei.

In: Molecular and Cellular Proteomics, Vol. 10, No. 7, 01.07.2011.

Research output: Contribution to journalArticle

Chen, T, Xie, G, Wang, X, Fan, J, Qiu, Y, Zheng, X, Qi, X, Cao, Y, Su, M, Wang, X, Xu, LX, Yen, Y, Liu, P & Jia, W 2011, 'Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma', Molecular and Cellular Proteomics, vol. 10, no. 7. https://doi.org/10.1074/mcp.M110.004945
Chen, Tianlu ; Xie, Guoxiang ; Wang, Xiaoying ; Fan, Jia ; Qiu, Yunping ; Zheng, Xiaojiao ; Qi, Xin ; Cao, Yu ; Su, Mingming ; Wang, Xiaoyan ; Xu, Lisa X. ; Yen, Yun ; Liu, Ping ; Jia, Wei. / Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. In: Molecular and Cellular Proteomics. 2011 ; Vol. 10, No. 7.
@article{a0bf8b64c6f344db8ce333aae6c35c13,
title = "Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma",
abstract = "Hepatocellular carcinoma (HCC) is a common malignancy in the world with high morbidity and mortality rate. Identification of novel biomarkers in HCC remains impeded primarily because of the heterogeneity of the disease in clinical presentations as well as the pathophysiological variations derived from underlying conditions such as cirrhosis and steatohepatitis. The aim of this study is to search for potential metabolite biomarkers of human HCC using serum and urine metabolomics approach. Sera and urine samples were collected from patients with HCC (n = 82), benign liver tumor patients (n = 24), and healthy controls (n = 71). Metabolite profiling was performed by gas chromatography time-of-flight mass spectrometry and ultra performance liquid chromatography-quadrupole time of flight mass spectrometry in conjunction with univariate and multivariate statistical analyses. Forty three serum metabolites and 31 urinary metabolites were identified in HCC patients involving several key metabolic pathways such as bile acids, free fatty acids, glycolysis, urea cycle, and methionine metabolism. Differentially expressed metabolites in HCC subjects, such as bile acids, histidine, and inosine are of great statistical significance and high fold changes, which warrant further validation as potential biomarkers for HCC. However, alterations of several bile acids seem to be affected by the condition of liver cirrhosis and hepatitis. Quantitative measurement and comparison of seven bile acids among benign liver tumor patients with liver cirrhosis and hepatitis, HCC patients with liver cirrhosis and hepatitis, HCC patients without liver cirrhosis and hepatitis, and healthy controls revealed that the abnormal levels of glycochenodeoxycholic acid, glycocholic acid, taurocholic acid, and chenodeoxycholic acid are associated with liver cirrhosis and hepatitis. HCC patients with alpha fetoprotein values lower than 20 ng/ml was successfully differentiated from healthy controls with an accuracy of 100{\%} using a panel of metabolite markers. Our work shows that metabolomic profiling approach is a promising screening tool for the diagnosis and stratification of HCC patients.",
author = "Tianlu Chen and Guoxiang Xie and Xiaoying Wang and Jia Fan and Yunping Qiu and Xiaojiao Zheng and Xin Qi and Yu Cao and Mingming Su and Xiaoyan Wang and Xu, {Lisa X.} and Yun Yen and Ping Liu and Wei Jia",
year = "2011",
month = "7",
day = "1",
doi = "10.1074/mcp.M110.004945",
language = "English",
volume = "10",
journal = "Molecular and Cellular Proteomics",
issn = "1535-9476",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "7",

}

TY - JOUR

T1 - Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma

AU - Chen, Tianlu

AU - Xie, Guoxiang

AU - Wang, Xiaoying

AU - Fan, Jia

AU - Qiu, Yunping

AU - Zheng, Xiaojiao

AU - Qi, Xin

AU - Cao, Yu

AU - Su, Mingming

AU - Wang, Xiaoyan

AU - Xu, Lisa X.

AU - Yen, Yun

AU - Liu, Ping

AU - Jia, Wei

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Hepatocellular carcinoma (HCC) is a common malignancy in the world with high morbidity and mortality rate. Identification of novel biomarkers in HCC remains impeded primarily because of the heterogeneity of the disease in clinical presentations as well as the pathophysiological variations derived from underlying conditions such as cirrhosis and steatohepatitis. The aim of this study is to search for potential metabolite biomarkers of human HCC using serum and urine metabolomics approach. Sera and urine samples were collected from patients with HCC (n = 82), benign liver tumor patients (n = 24), and healthy controls (n = 71). Metabolite profiling was performed by gas chromatography time-of-flight mass spectrometry and ultra performance liquid chromatography-quadrupole time of flight mass spectrometry in conjunction with univariate and multivariate statistical analyses. Forty three serum metabolites and 31 urinary metabolites were identified in HCC patients involving several key metabolic pathways such as bile acids, free fatty acids, glycolysis, urea cycle, and methionine metabolism. Differentially expressed metabolites in HCC subjects, such as bile acids, histidine, and inosine are of great statistical significance and high fold changes, which warrant further validation as potential biomarkers for HCC. However, alterations of several bile acids seem to be affected by the condition of liver cirrhosis and hepatitis. Quantitative measurement and comparison of seven bile acids among benign liver tumor patients with liver cirrhosis and hepatitis, HCC patients with liver cirrhosis and hepatitis, HCC patients without liver cirrhosis and hepatitis, and healthy controls revealed that the abnormal levels of glycochenodeoxycholic acid, glycocholic acid, taurocholic acid, and chenodeoxycholic acid are associated with liver cirrhosis and hepatitis. HCC patients with alpha fetoprotein values lower than 20 ng/ml was successfully differentiated from healthy controls with an accuracy of 100% using a panel of metabolite markers. Our work shows that metabolomic profiling approach is a promising screening tool for the diagnosis and stratification of HCC patients.

AB - Hepatocellular carcinoma (HCC) is a common malignancy in the world with high morbidity and mortality rate. Identification of novel biomarkers in HCC remains impeded primarily because of the heterogeneity of the disease in clinical presentations as well as the pathophysiological variations derived from underlying conditions such as cirrhosis and steatohepatitis. The aim of this study is to search for potential metabolite biomarkers of human HCC using serum and urine metabolomics approach. Sera and urine samples were collected from patients with HCC (n = 82), benign liver tumor patients (n = 24), and healthy controls (n = 71). Metabolite profiling was performed by gas chromatography time-of-flight mass spectrometry and ultra performance liquid chromatography-quadrupole time of flight mass spectrometry in conjunction with univariate and multivariate statistical analyses. Forty three serum metabolites and 31 urinary metabolites were identified in HCC patients involving several key metabolic pathways such as bile acids, free fatty acids, glycolysis, urea cycle, and methionine metabolism. Differentially expressed metabolites in HCC subjects, such as bile acids, histidine, and inosine are of great statistical significance and high fold changes, which warrant further validation as potential biomarkers for HCC. However, alterations of several bile acids seem to be affected by the condition of liver cirrhosis and hepatitis. Quantitative measurement and comparison of seven bile acids among benign liver tumor patients with liver cirrhosis and hepatitis, HCC patients with liver cirrhosis and hepatitis, HCC patients without liver cirrhosis and hepatitis, and healthy controls revealed that the abnormal levels of glycochenodeoxycholic acid, glycocholic acid, taurocholic acid, and chenodeoxycholic acid are associated with liver cirrhosis and hepatitis. HCC patients with alpha fetoprotein values lower than 20 ng/ml was successfully differentiated from healthy controls with an accuracy of 100% using a panel of metabolite markers. Our work shows that metabolomic profiling approach is a promising screening tool for the diagnosis and stratification of HCC patients.

UR - http://www.scopus.com/inward/record.url?scp=84855206110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855206110&partnerID=8YFLogxK

U2 - 10.1074/mcp.M110.004945

DO - 10.1074/mcp.M110.004945

M3 - Article

C2 - 21518826

AN - SCOPUS:84855206110

VL - 10

JO - Molecular and Cellular Proteomics

JF - Molecular and Cellular Proteomics

SN - 1535-9476

IS - 7

ER -